GILD:NGS-Gilead Sciences Inc. (USD)

EQUITY | Drug Manufacturers - General | Nasdaq Global Select

Last Closing

USD 94.11

Change

0.00 (0.00)%

Market Cap

USD 98.10B

Volume

3.35M

Analyst Target

USD 77.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

N/A

USD 202.63B
AMGN Amgen Inc

N/A

USD 141.18B
SNY Sanofi ADR

N/A

USD 119.62B
BIIB Biogen Inc

N/A

USD 22.16B
GRFS Grifols SA ADR

N/A

USD 7.13B
AMRN Amarin Corporation PLC

N/A

USD 0.18B
MIRA MIRA Pharmaceuticals, Inc. Com..

N/A

USD 0.02B
SCLX Scilex Holding Company

N/A

N/A
SCLXW Scilex Holding Company

N/A

N/A

ETFs Containing GILD

BBH VanEck Biotech ETF 11.80 % 0.35 %

N/A

USD 0.40B
IBB iShares Biotechnology ETF 8.58 % 0.47 %

N/A

USD 6.53B
BTEC:SW iShares Nasdaq US Biotech.. 8.25 % 0.00 %

N/A

N/A
UBIO 7.77 % 0.95 %

N/A

N/A
BIS ProShares UltraShort Nasd.. 7.41 % 0.95 %

N/A

USD 4.38M
BIB ProShares Ultra Nasdaq Bi.. 6.55 % 0.95 %

N/A

USD 0.06B
FHI:CA CI Health Care Giants Cov.. 5.83 % 0.75 %

N/A

CAD 0.08B
XDNA:CA iShares Genomics Immunolo.. 5.68 % 0.00 %

N/A

CAD 5.33M
TBG EA Series Trust 4.41 % 0.00 %

N/A

USD 0.10B
UDI USCF ETF Trust 4.00 % 0.00 %

N/A

N/A
JPHG:PA Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

N/A
JPHC:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 5.55M
JPHE:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.06B
JPHG:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 3.90M
JPHU:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.05B
JPNK:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.07B
JPNY:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 5.95B
QQQG Pacer Nasdaq 100 Top 50 C.. 3.66 % 0.00 %

N/A

USD 2.11M
BAMD Brookstone Dividend Stock.. 3.45 % 0.00 %

N/A

USD 0.09B
CBUF:F iShares V Public Limited .. 3.37 % 0.00 %

N/A

N/A
MDLV EA Series Trust - Morgan .. 3.19 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.19 % 0.00 %

N/A

N/A
QNXT iShares Nasdaq-100 ex Top.. 3.18 % 0.00 %

N/A

USD 0.01B
MOTV:LSE VanEck Morningstar US Wid.. 2.97 % 0.00 %

N/A

USD 0.05B
MOTU:LSE VanEck Morningstar US Wid.. 2.97 % 0.00 %

N/A

USD 0.05B
MHOT:AU VanEck Morningstar Wide M.. 2.94 % 0.00 %

N/A

N/A
MOAT:AU VanEck Morningstar Wide M.. 2.93 % 0.00 %

N/A

USD 1.05B
CURE:AU ETFS S&P Biotech ETF 2.80 % 0.00 %

N/A

USD 0.04B
WBIL WBI BullBear Quality 3000.. 2.55 % 1.07 %

N/A

USD 0.04B
WMOT:XETRA VanEck Morningstar US Wid.. 2.51 % 0.00 %

N/A

N/A
GOAT:AU VanEck Morningstar World .. 2.48 % 0.00 %

N/A

USD 0.04B
TDIV:SW VanEck Morningstar Develo.. 2.37 % 0.00 %

N/A

USD 1.19B
SDOG ALPS Sector Dividend Dogs.. 2.24 % 0.40 %

N/A

USD 1.18B
2B78:F iShares Healthcare Innova.. 2.23 % 0.00 %

N/A

N/A
HEAL:SW iShares Healthcare Innova.. 2.08 % 0.00 %

N/A

N/A
DHS:SW 2.04 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
LABU Direxion Daily S&P Biotec.. 2.01 % 1.14 %

N/A

USD 0.82B
SAGP The Advisorsa Inner Circl.. 1.93 % 0.00 %

N/A

USD 0.04B
RSPH Invesco S&P 500 Equal Wei.. 1.71 % 0.00 %

N/A

USD 0.83B
BBP Virtus LifeSci Biotech Pr.. 1.68 % 0.79 %

N/A

USD 0.02B
INCM:AU BetaShares Global Income .. 1.66 % 0.00 %

N/A

USD 0.03B
ZUH:CA BMO Equal Weight US Healt.. 1.60 % 0.39 %

N/A

CAD 0.23B
ZLU:CA BMO Low Volatility US Equ.. 1.59 % 0.33 %

N/A

CAD 1.91B
SPYD SPDR® Portfolio S&P 500 .. 1.49 % 0.08 %

N/A

USD 6.71B
MVEW:LSE iShares Edge MSCI World M.. 1.45 % 0.00 %

N/A

USD 0.30M
MVEC:SW iShares Edge MSCI World M.. 1.36 % 0.00 %

N/A

USD 0.17B
MVEW:SW iShares Edge MSCI World M.. 1.36 % 0.00 %

N/A

USD 0.43B
MVWE:SW iShares Edge MSCI World M.. 1.36 % 0.00 %

N/A

USD 0.07B
EVO:CA Evovest Global Equity ETF 0.96 % 0.00 %

N/A

N/A
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.59 % 0.00 %

N/A

N/A
FVD:LSE First Trust Value Line® .. 0.51 % 0.00 %

N/A

USD 7.19M
JIGB 0.41 % 0.14 %

N/A

N/A
BSCK 0.00 % 0.10 %

N/A

N/A
BSCL 0.00 % 0.10 %

N/A

N/A
BSCQ Invesco BulletShares 2026.. 0.00 % 0.10 %

N/A

N/A
CBND 0.00 % 0.16 %

N/A

N/A
DVP Roundhill Acquirers Deep .. 0.00 % 0.48 %

N/A

N/A
ESGW 0.00 % 0.40 %

N/A

N/A
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

N/A

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
IBCD 0.00 % 0.10 %

N/A

N/A
MOAT VanEck Morningstar Wide M.. 0.00 % 0.49 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

N/A
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

N/A

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

USD 0.01B
IVFVC 0.00 % 0.00 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
IDNA iShares Genomics Immunolo.. 0.00 % 0.00 %

N/A

USD 0.12B
ZLU-U:CA BMO Low Volatility US Equ.. 0.00 % 0.00 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
SPBO SPDR Portfolio Corporate .. 0.00 % 0.00 %

N/A

USD 1.90B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
RJZ 0.00 % 0.75 %

N/A

N/A
SCIU 0.00 % 0.19 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

N/A

N/A
XMS:CA iShares Edge MSCI Min Vol.. 0.00 % 0.33 %

N/A

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

N/A

N/A
FCW:CA 0.00 % 0.90 %

N/A

N/A
SPDV AAM S&P 500 High Dividend.. 0.00 % 0.29 %

N/A

USD 0.06B
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

N/A

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

N/A

N/A
JPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 5.55M
UBBB:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.13B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP4H:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
VDIV:F VanEck Vectors ETFs N.V... 0.00 % 0.00 %

N/A

USD 0.64B
WTD9:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 1.59M
WTEU:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.11B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
2B78:XETRA iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

USD 1.14B
JP40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.05B
JP4H:XETRA 0.00 % 0.00 %

N/A

N/A
VDIV:XETRA VanEck Morningstar Develo.. 0.00 % 0.00 %

N/A

USD 0.64B
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.11B
TQGD:CA TD Q Global Dividend ETF 0.00 % 0.00 %

N/A

CAD 0.19B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
HDLB ETRACS Monthly Pay 2xLeve.. 0.00 % 0.00 %

N/A

USD 8.95M
MVEW:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

USD 0.78B
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
SIXA 6 Meridian Mega Cap Equit.. 0.00 % 0.00 %

N/A

USD 0.29B
BMED BlackRock Future Health E.. 0.00 % 0.00 %

N/A

USD 4.16M
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

USD 1.13B
FBT:LSE First Trust Global Funds .. 0.00 % 0.00 %

N/A

USD 8.11M
FBTU:LSE First Trust Global Funds .. 0.00 % 0.00 %

N/A

USD 8.11M
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

N/A

CAD 0.09B
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

N/A

USD 0.04B
GDOC Goldman Sachs ETF Trust 0.00 % 0.00 %

N/A

USD 0.02B
CSY9:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.29B
WDMVO:SW UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.29B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.17% 100% F 71% C-
Dividend Return 3.80% 75% C 64% D
Total Return 19.97% 100% F 73% C
Trailing 12 Months  
Capital Gain 16.17% 100% F 71% C-
Dividend Return 3.80% 75% C 64% D
Total Return 19.97% 100% F 73% C
Trailing 5 Years  
Capital Gain 44.94% 100% F 72% C
Dividend Return 22.42% 100% F 81% B-
Total Return 67.36% 100% F 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 0.58% 70% C- 40% F
Dividend Return 4.17% 70% C- 47% F
Total Return 3.59% 80% B- 74% C
Risk Return Profile  
Volatility (Standard Deviation) 24.86% 60% D- 70% C-
Risk Adjusted Return 16.76% 70% C- 48% F
Market Capitalization 98.10B 63% D 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 7.00 14% 1%
Price/Book Ratio 6.20 25% 21%
Price / Cash Flow Ratio 14.38 63% 22%
Price/Free Cash Flow Ratio 33.87 13% 12%
Management Effectiveness  
Return on Equity 0.56% 38% 59%
Return on Invested Capital 18.78% 100% 86%
Return on Assets 11.96% 100% 96%
Debt to Equity Ratio 101.56% 50% 23%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector